Global Pricing Controls Will Erode CNS Drug Portfolios

Published
26 Jun 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
DKK 38.00
1.6% overvalued intrinsic discount
16 Aug
DKK 38.60
Loading
1Y
-11.4%
7D
9.5%

Author's Valuation

DKK 38.0

1.6% overvalued intrinsic discount

AnalystLowTarget Fair Value